InsidersTradesSigma
Track the Zelluna ASA stock price and the full management transaction log of the company, a listed issuer based in Norway. Shares are quoted on the NO market, under the oversight of Oslo Børs. Operating in the Health Care sector, Zelluna ASA has recorded 30 public disclosures. The latest transaction was filed on 2 July 2026 (Option grant). Among the most active insiders: Chief Executive. The full history is free.
30
Insider Decl.
n/a
Thresholds
€591,870
21 ops.
Buy Volume
€1bn
3 ops.
Sell Volume
10Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 July 2026
Declarations30 total
@ €1.6684OptionXOSLOSLO:677565
@ €1.6315ShareXOSLOSLO:677249
ShareXOSLOSLO:676434
@ €1.6528OptionXOSLOSLO:669613
@ €0.0876ShareXOSLOSLO:643069
ShareXOSLOSLO:642269
2,024,400,000 shares@ NOK 7.898499.9% of flowShareXOSLOSLO:613038
140,000 shares@ NOK 7.25070.0% of flowShareXOSLOSLO:613037
596,006 shares@ NOK 9.52450.0% of flowShareXOSLOSLO:612956
500 shares@ NOK 130.004.8% of flowOptionXOSLOSLO:608023
1,500 shares@ NOK 119.7513.2% of flowOptionXOSLOSLO:607867
500 shares@ NOK 114.004.0% of flowOptionXOSLOSLO:604609
5,300 shares@ NOK 93.950.0% of flowShareXOSLOSLO:603354
7,000 shares@ NOK 79.51590.0% of flowShareXOSLOSLO:592830
7,100 shares@ NOK 70.000.0% of flowShareXOSLOSLO:592748
1,500 shares@ NOK 96.705811.6% of flowOptionXOSLOSLO:576959
5,250 shares@ NOK 94.5580.0% of flowShareXOSLOSLO:575427
2,000 shares@ NOK 67.1011.2% of flowOptionXOSLOSLO:570550
2,000 shares@ NOK 69.5011.1% of flowOptionXOSLOSLO:566134
1,000 shares@ NOK 93.667.6% of flowOptionXOSLOSLO:554112
1,000 shares@ NOK 107.608.6% of flowOptionXOSLOSLO:548429
1,000 shares@ NOK 114.009.2% of flowOptionXOSLOSLO:548142
5,000 shares@ NOK 77.68080.0% of flowShareXOSLOSLO:534618
500 shares@ NOK 79.003.2% of flowOptionXOSLOSLO:534102
25 of 30 declarations
About Zelluna ASA
Zelluna ASA is a company focused on the health and pharmaceutical sector, specializing in the development of immunological therapies. It is listed on the XOSL market.
